Synthesis and evaluation of a near-infrared fluorescent non-peptidic bivalent integrin αvβ3 antagonist for cancer imaging

Bioconjugate Chemistry

Volumn 21, Issue 2, 2010, Pages 270-278

  Li, Feng ^a   Liu, Jiacheng ^a   Jas, Gouri S ^b   Zhang, Jiawei ^a   Qin, Guoting ^a   Xing, Jiong ^a   Cotes, Claudia ^a   Zhao, Hong ^a   Wang, Xukui ^a   Diaz, Laura A ^a   Shi, Zheng Zheng ^a   Lee, Daniel Y ^a   Li, King C P ^a   Li, Zheng ^a  

^a HOUSTON METHODIST RESEARCH INSTITUTE   (United States)

^b BAYLOR UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 [2 (3,4,5,6 TETRAHYDROPYRIMIDIN 2 YLAMINO)ETHYLOXY]BENZOYL 2 AMINOETHYLSULFONYLAMINOALANINE DERIVATIVE; CYANINE DYE 5; RECEPTOR BLOCKING AGENT; UNCLASSIFIED DRUG; VITRONECTIN RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; DIAGNOSTIC IMAGING; DRUG ACCUMULATION; DRUG RECEPTOR BINDING; DRUG SYNTHESIS; ENDOCYTOSIS; EVALUATION; FEMALE; FLUORESCENCE; FLUORESCENCE MICROSCOPY; GLIOBLASTOMA; HUMAN; HUMAN CELL; IC 50; IMAGING SYSTEM; MOLECULAR IMAGING; MOUSE; NONHUMAN; REACTION ANALYSIS; RECEPTOR AFFINITY;

EID: 77049113046     PISSN: 10431802     EISSN: 15204812     Source Type: Journal    
DOI: 10.1021/bc900313d     Document Type: Article

References (20)

1. Brooks, P. C., Clark, R. A., and Cheresh, D. A. (1994) Requirement of vascular integrin alpha v beta 3 for angiogenesis. Science 264, 569-571
2. Hood, J. D., Bednarski, M., Frausto, R., Guccione, S., Reisfeld, R. A., Xiang, R., and Cheresh, D. A. (2002) Tumor regression by targeted gene delivery to the neovasculature. Science 296, 2404-2407
3. Takagi, J., and Springer, T. A. (2002) Integrin activation and structural rearrangement. Immunol. Rev. 186, 141-163
4. Delbaldo, C., Raymond, E., Vera, K., Hammershaimb, L., Kaucic, K., Lozahic, S., Marty, M., and Faivre, S. (2008) Phase I and pharmacokinetic study of etaracizumab (Abegrin), a humanized monoclonal antibody against alphavbeta3 integrin receptor, in patients with advanced solid tumors. InVest. New Drugs 26, 35-43.
5. Schottelius, M., Laufer, B., Kessler, H., and Wester, H. J. (2009) Ligands for mapping αvβ3-integrin expression in vivo. Acc Chem Res 42, 969-980
6. Chen, X., Conti, P. S., and Moats, R. A. (2004) In vivo nearinfrared fluorescence imaging of integrin alphavbeta3 in brain tumor xenografts. Cancer Res. 64, 8009-8014
7. Cheng, Z., Wu, Y., Xiong, Z., Gambhir, S. S., and Chen, X. (2005) Near-infrared fluorescent RGD peptides for optical imaging of integrin alphavbeta3 expression in living mice. Bioconjugate Chem. 16, 1433-1441
8. Burnett, C. A., Xie, J., Quijano, J., Shen, Z., Hunter, F., Bur, M., Li, K. C., and Danthi, S. N. (2005) Synthesis, in vitro, and in vivo characterization of an integrin alpha(v)beta(3)-targeted molecular probe for optical imaging of tumor. Bioorg. Med. Chem. 13, 3763-3771
9. Xie, J., Shen, Z., Li, K. C., and Danthi, N. (2007) Tumor angiogenic endothelial cell targeting by a novel integrin-targeted nanoparticle. Int. J. Nanomed. 2, 479-485
10. Ntziachristos, V., Bremer, C., and Weissleder, R. (2003) Fluorescence imaging with near-infrared light: new technological advances that enable in vivo molecular imaging. Eur. Radiol. 13, 195-208.
11. Sevick-Muraca, E. M., Houston, J. P., and Gurfinkel, M. (2002) Fluorescence-enhanced, near infrared diagnostic imaging with contrast agents. Curr. Opin. Chem. Biol. 6, 642-650
12. Morris, G. M., Goodsell, D. S., Halliday, R. S., Huey, R., Hart, W. E., Belew, R. K., and Olson, A. J. (1998) Automated docking using a Lamarckian genetic algorithm and empirical binding free energy function. J. Comput. Chem. 19, 1639-1662.
13. Goodsell, D. S., and Olson, A. J. (1990) Automated docking of substrates to proteins by simulated annealing. Proteins 8, 195-202.
14. Morris, G. M., Goodsell, D. S., Huey, R., and Olson, A. J. (1996) Distributed automated docking of flexible ligands to proteins: parallel applications of AutoDock 2.4. J. Comput. Aided Mol. Des. 10, 293-304.
15. Xiong, J. P., Stehle, T., Zhang, R., Joachimiak, A., Frech, M., Goodman, S. L., and Arnaout, M. A. (2002) Crystal structure of the extracellular segment of integrin alpha Vbeta3 in complex with an Arg-Gly-Asp ligand. Science 296, 151-155
16. Cheng, Z., Levi, J., Xiong, Z., Gheysens, O., Keren, S., Chen, X., and Gambhir, S. S. (2006) Near-infrared fluorescent deoxyglucose analogue for tumor optical imaging in cell culture and living mice. Bioconjugate Chem. 17, 662-669
17. Parsons, D. W., Jones, S., Zhang, X., Lin, J. C., Leary, R. J., Angenendt, P., Mankoo, P., Carter, H., Siu, I. M., Gallia, G. L., Olivi, A., McLendon, R., Rasheed, B. A., Keir, S., Nikolskaya, T., Nikolsky, Y., Busam, D. A., Tekleab, H., Diaz, L. A., Jr., Hartigan, J., Smith, D. R., Strausberg, R. L., Marie, S. K., Shinjo, S. M., Yan, H., Riggins, G. J., Bigner, D. D., Karchin, R., Papadopoulos, N., Parmigiani, G., Vogelstein, B., Velculescu, V. E., and Kinzler, K. W. (2008) An integrated genomic analysis of human glioblastoma multiforme. Science 321, 1807-1812
18. Kanu, O. O., Mehta, A., Di, C., Lin, N., Bortoff, K., Bigner, D. D., Yan, H., and Adamson, D. C. (2009) Glioblastoma multiforme: a review of therapeutic targets. Expert Opin. Ther. Targets 13, 701-718
19. Rao, J., Lahiri, J., Isaacs, L., Weis, R. M., and Whitesides, G. M. (1998) A trivalent system from vancomycin.D-ala-D-Ala with higher affinity than avidin.biotin. Science 280, 708-711
20. Mulder, A., Huskens, J., and Reinhoudt, D. N. (2004) Multivalency in supramolecular chemistry and nanofabrication. Org. Biomol. Chem. 2, 3409-3424